• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哌醋甲酯用于中风后早期恢复:一项双盲、安慰剂对照研究。

Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.

作者信息

Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B

机构信息

Department of Psychiatry, Milwaukee Clinical Campus, University of Wisconsin School of Medicine, USA.

出版信息

Arch Phys Med Rehabil. 1998 Sep;79(9):1047-50. doi: 10.1016/s0003-9993(98)90169-1.

DOI:10.1016/s0003-9993(98)90169-1
PMID:9749682
Abstract

OBJECTIVE

To determine the efficacy and safety of methylphenidate in acute stroke rehabilitation.

DESIGN

A prospective, randomized, double-blind, placebo-controlled study.

PATIENTS AND SETTING

Twenty-one stroke patients consecutively admitted to a community-based rehabilitation unit.

INTERVENTION

Three-week treatment of methylphenidate (or placebo) in conjunction with physical therapy. Methylphenidate was started at 5mg and increased gradually to 30mg (15mg at 8:00AM and 15mg at 12:00 noon), and discontinued before discharge.

MAIN OUTCOME MEASURES

Mood measures included the Hamilton Depression Rating Scale (HAM-D) and Zung Self-Rating Depression Scale (ZDS). Cognitive status was evaluated using the Mini-Mental State Exam (MMSE). Motor functioning was assessed using the Fugl-Meyer Scale (FMS) and a modified version of the Functional Independence Measure (M-FIM). All measures were administered pretreatment and weekly thereafter. Side effects were measured after each increase in dosage and weekly.

RESULTS

Patients receiving methylphenidate treatment scored lower on the HAM-D (F(1,18)=5.714, p=.028), lower on the ZDS (F(1,18)=4.206, p=.055), higher on the M-FIM (F(1,18)=5.374, p=.032), and higher on the FMS (F(1,9)=4.060, p=.075) than patients receiving placebo.

CONCLUSION

Methylphenidate appears to be a safe and effective intervention in early poststroke rehabilitation that may expedite recovery.

摘要

目的

确定哌醋甲酯在急性脑卒中康复中的疗效和安全性。

设计

一项前瞻性、随机、双盲、安慰剂对照研究。

患者和研究地点

连续纳入21名入住社区康复单元的脑卒中患者。

干预措施

哌醋甲酯(或安慰剂)联合物理治疗,为期3周。哌醋甲酯起始剂量为5mg,逐渐增加至30mg(上午8点15mg,中午12点15mg),出院前停药。

主要观察指标

情绪测量指标包括汉密尔顿抑郁量表(HAM-D)和zung自评抑郁量表(ZDS)。使用简易精神状态检查表(MMSE)评估认知状态。使用Fugl-Meyer量表(FMS)和改良版功能独立性测量表(M-FIM)评估运动功能。所有测量均在治疗前及此后每周进行一次。每次增加剂量后及每周测量副作用。

结果

与接受安慰剂治疗的患者相比,接受哌醋甲酯治疗的患者在HAM-D量表上得分更低(F(1,18)=5.714,p=0.028),在ZDS量表上得分更低(F(1,18)=4.206,p=0.055),在M-FIM量表上得分更高(F(1,18)=5.374,p=0.032),在FMS量表上得分更高(F(1,9)=4.060,p=0.075)。

结论

哌醋甲酯似乎是脑卒中后早期康复中一种安全有效的干预措施,可能会加速康复。

相似文献

1
Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study.哌醋甲酯用于中风后早期恢复:一项双盲、安慰剂对照研究。
Arch Phys Med Rehabil. 1998 Sep;79(9):1047-50. doi: 10.1016/s0003-9993(98)90169-1.
2
A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.一项关于精神兴奋剂治疗人类免疫缺陷病毒病门诊患者疲劳的随机、双盲、安慰剂对照试验。
Arch Intern Med. 2001 Feb 12;161(3):411-20. doi: 10.1001/archinte.161.3.411.
3
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.一项关于使用哌甲酯缓释制剂对难治性抑郁症门诊患者进行增效治疗的随机、双盲、安慰剂对照试验。
J Clin Psychopharmacol. 2006 Dec;26(6):653-6. doi: 10.1097/01.jcp.0000246212.03530.fd.
4
Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.美金刚治疗轻度阿尔茨海默病社区居住老年退伍军人淡漠症状的双盲、随机、安慰剂对照试验
Am J Psychiatry. 2018 Feb 1;175(2):159-168. doi: 10.1176/appi.ajp.2017.17030316. Epub 2017 Sep 15.
5
Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.哌醋甲酯和/或左旋多巴联合物理疗法对脑卒中后功能和运动恢复的影响——一项随机、双盲、安慰剂对照试验。
Acta Neurol Scand. 2011 Apr;123(4):266-73. doi: 10.1111/j.1600-0404.2010.01395.x.
6
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.比较哌甲酯、舍曲林和安慰剂对创伤性脑损伤患者神经精神后遗症的影响。
Hum Psychopharmacol. 2005 Mar;20(2):97-104. doi: 10.1002/hup.668.
7
Efficacy and side effects of methylphenidate for poststroke depression.
J Clin Psychiatry. 1992 Dec;53(12):447-9.
8
Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.20 毫克哌醋甲酯治疗 1 型肌强直性营养不良成人日间嗜睡的疗效和耐受性:2 中心、随机、双盲、安慰剂对照、3 周交叉试验。
Clin Ther. 2012 May;34(5):1103-11. doi: 10.1016/j.clinthera.2012.03.060.
9
Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.右苯丙胺对脑卒中后运动功能恢复的影响:一项随机临床试验。
JAMA Neurol. 2018 Dec 1;75(12):1494-1501. doi: 10.1001/jamaneurol.2018.2338.
10
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial.哌醋甲酯治疗阿尔茨海默病患者淡漠症状的安全性和有效性:一项随机、安慰剂对照试验。
J Clin Psychiatry. 2013 Aug;74(8):810-6. doi: 10.4088/JCP.12m08099.

引用本文的文献

1
Efficacy of Methylphenidate in Patients With Brain Disease: A Systematic Review and Meta-Analysis.哌醋甲酯治疗脑部疾病患者的疗效:一项系统评价和荟萃分析。
Brain Neurorehabil. 2025 Jun 20;18(2):e4. doi: 10.12786/bn.2025.18.e4. eCollection 2025 Jul.
2
Safety of Stimulants Across Patient Populations: A Meta-Analysis.不同患者群体中兴奋剂的安全性:一项荟萃分析。
JAMA Netw Open. 2025 May 1;8(5):e259492. doi: 10.1001/jamanetworkopen.2025.9492.
3
Neurostimulant Use for Rehabilitation and Recovery After Stroke: A Narrative Literature Review.
用于中风后康复和恢复的神经兴奋剂:一篇叙述性文献综述。
Stroke. 2025 Jul;56(7):1853-1871. doi: 10.1161/STROKEAHA.124.048677. Epub 2025 Apr 18.
4
Effect of amphetamines on blood pressure.安非他命对血压的影响。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD007896. doi: 10.1002/14651858.CD007896.pub4.
5
Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells.苯丙胺和哌醋甲酯对SH-SY5Y细胞中多巴胺能神经毒物的保护作用。
Curr Res Toxicol. 2024 Mar 20;6:100165. doi: 10.1016/j.crtox.2024.100165. eCollection 2024.
6
Effect of psychostimulant medications on physical function in children with cerebral palsy: scoping review.精神兴奋剂药物对脑瘫儿童身体功能的影响:范围综述。
Pediatr Res. 2024 Apr;95(5):1217-1223. doi: 10.1038/s41390-023-02933-3. Epub 2023 Dec 9.
7
Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review.卒中后抑郁的病理生理学和现行药物治疗:综述。
Int J Mol Sci. 2022 Dec 1;23(23):15114. doi: 10.3390/ijms232315114.
8
Stability of extemporaneously prepared preservative-free methylphenidate 5 mg/mL intravenous solution.临用前配制的无防腐剂哌醋甲酯 5mg/mL 静脉溶液的稳定性。
Am J Health Syst Pharm. 2022 Feb 18;79(5):359-363. doi: 10.1093/ajhp/zxab420.
9
Pharmacological, psychological and non-invasive brain stimulation interventions for preventing depression after stroke.用于预防中风后抑郁症的药理学、心理学和非侵入性脑刺激干预措施。
Cochrane Database Syst Rev. 2020 May 11;5(5):CD003689. doi: 10.1002/14651858.CD003689.pub4.
10
Effects of Dopamine on Motor Recovery and Training in Adults and Children With Nonprogressive Neurological Injuries: A Systematic Review.多巴胺对非进行性神经损伤成人和儿童运动康复及训练的影响:系统评价。
Neurorehabil Neural Repair. 2019 May;33(5):331-344. doi: 10.1177/1545968319837289. Epub 2019 Mar 27.